This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akin, E.
Right arrow Articles by Tucker, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akin, E.
Right arrow Articles by Tucker, L. B.
Related Collections
Right arrow Therapeutics & Toxicology

PEDIATRICS Vol. 101 No. 5 May 1998, pp. 926-928

EXPERIENCE AND REASON:
Minocycline-induced Lupus in Adolescents

The first 20% of the full text of this article appears below.

    INTRODUCTION

Minocycline is a semisynthetic tetracycline antibiotic with a prolonged half-life. Its chief indications are the treatment of Rickettsia, Mycoplasma, Chlamydia, and Brucella infections, but it is also commonly used for the treatment of acne in doses of 50 to 100 mg daily.1 Its side effects include skin and tooth discoloration, gastrointestinal intolerance, hemolytic anemia, elevations in blood urea nitrogen, pneumonitis, and hepatitis. Also, a minocycline-related lupus-like syndrome presenting with findings including fever, arthritis, and rash has been reported mostly in young adults.2-7 We report five adolescent girls who developed lupus-like syndromes during treatment with minocycline for acne, so as to promote physician awareness, as differentiating this syndrome from genuine systemic lupus erythematosus (SLE) has important therapeutic and prognostic implications.

    METHODS AND PATIENTS

The patients were girls ranging in age from 14 to 17 years who were referred to the pediatric rheumatology clinic at the Floating Hospital for Children by their primary pediatricians because of suspected lupus or other rheumatic disease. Drug exposures were sought during routine history taking. Serologic tests were performed at the New England Medical Center using standard methods. Antihistone antibodies were assayed at a commercial laboratory (Smithkline Beecham, Framingham, MA).

Case Report

Patient 2, a 16-year-old girl, presented with 2 weeks of daily fevers, fatigue, and diffuse arthralgias beginning 12 hours after receiving hepatitis B and diphteria-tetanus vaccines. She had been taking minocycline . . . [Full Text of this Article]


This article has been cited by other articles:


Home page
 BrainHome page
V. Brundula, N. B. Rewcastle, L. M. Metz, C. C. Bernard, and V. W. Yong
Targeting leukocyte MMPs and transmigration: Minocycline as a potential therapy for multiple sclerosis
Brain, June 1, 2002; 125(6): 1297 - 1308.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
T. M. Lawson, N. Amos, D. Bulgen, and B. D. Williams
Minocycline-induced lupus: clinical features and response to rechallenge
Rheumatology, March 1, 2001; 40(3): 329 - 335.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
R. Corona
Minocycline in Acne Is Still an Issue
Arch Dermatol, September 1, 2000; 136(9): 1143 - 1145.
[Full Text] [PDF]

Home page
 LupusHome page
C. Tournigand, T. Genereau, M. Prudent, M.-C. Diemert, S. Herson, and O. Chosidow
Minocycline-induced clinical and biological lupus-like disease
Lupus, November 1, 1999; 8(9): 773 - 774.
[Abstract] [PDF]

Home page
 ChestHome page
C. S. Christodoulou, P. Emmanuel, R. A. Ray, R. A. Good, B. M. Schnapf, and G. D. Cawkwell
Respiratory Distress Due to Minocycline-Induced Pulmonary Lupus
Chest, May 1, 1999; 115(5): 1471 - 1473.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
J. E. Teitelbaum, A. R. Perez-Atayde, M. Cohen, A. Bousvaros, and M. M. Jonas
Minocycline-Related Autoimmune Hepatitis: Case Series and Literature Review
Arch Pediatr Adolesc Med, November 1, 1998; 152(11): 1132 - 1136.
[Abstract] [Full Text] [PDF]